X0306 4/A 2021-12-23 2021-12-28 0 0001822711 PARDES BIOSCIENCES, INC. PRDS 0001581754 Tananbaum James B. C/O PARDES BIOSCIENCES, INC. 2173 SALK AVE, SUITE 250, PMB#052 CARLSBAD CA 92008 1 0 1 0 0001792204 Foresite Capital Fund V, L.P. 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939 0 0 1 0 0001792206 Foresite Capital Management V, LLC 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939 0 0 1 0 0001792205 Foresite Capital Opportunity Fund V, L.P. 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939 0 0 1 0 0001792207 Foresite Capital Opportunity Management V, LLC 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939 0 0 1 0 Common Stock 2021-12-23 4 C 0 4941250 0.00 A 4941250 I See Footnote Common Stock 0.00 2021-12-23 4 C 0 4941250 0.00 D Common Stock 4941250 0 I See Footnote In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. These shares are held by FS Development Holdings II, LLC ("FSD Holdings II"). Each of Foresite Capital Management V, LLC ("FCMVLLC"), Foresite Capital Opportunity Management V, LLC ("FCOMVLLC"), Foresite Capital Fund V, L.P. ("Capital Fund V L.P."), Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V L.P.") and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein. On December 28, 2021, the reporting person filed a Form 4 which contained a clerical error reporting that the reporting person beneficially owned 4,873,750 shares of Class B Common Stock of FS Development Corp. II prior to its business combination. In fact, as reported in this Form 4 Amendment, the reporting person beneficially owned 4,941,250 shares of Class B Common Stock. These shares are held by FSD Holdings II. Each of FCMVLLC, FCOMVLLC, Capital Fund V L.P., Opportunity Fund V L.P. and Dr. Tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein. /s/ Elizabeth Lacy, Attorney-in-Fact for James B. Tananbaum 2021-12-30 /s/ Dennis Ryan, on behalf of Foresite Capital Fund V, L.P. 2021-12-30 /s/ Dennis Ryan, on behalf of Foresite Capital Management V, LLC 2021-12-30 /s/ Dennis Ryan, on behalf of Foresite Capital Opportunity Fund V, L.P. 2021-12-30 /s/ Dennis Ryan, on behalf of Foresite Capital Opportunity Management V, LLC 2021-12-30 /s/ Dennis Ryan, as Attorney-in-Fact for Foresite Capital Fund V, L.P., Foresite Capital Management V, LLC, Foresite Capital Opportunity Fund V, L.P. and Foresite Capital Opportunity Management V, LLC 2021-12-30